Conducteurs
Contrôlez votre état avant une visite médicale, une récupération de permis ou avant de reprendre le volant.
11-Drug Urine Test Drugdiag® 11
Laboratoire Toda Pharma
Expédition offerte
Dès 49 € d’achat
Laboratoire français
Marquage CE
Qualité médicale
ISO 13485
Choisir la quantité
1 unité
Prix standard
€14,94
€12,45 HT
Ajouter au panier
Livraison offerte
Pack de 5
€74,70
€62,25 HT
Ajouter au panier
Livraison offerte
Pack de 10
Économisez 10%
€134,46
€112,05 HT
Ajouter au panier
Livraison 24h offerte
Pack de 25
Économisez 15%
€317,48
€264,56 HT
Ajouter au panier
Réponse en 24h
Entreprises & Collectivités
Offre sur mesure
Unable to load the pickup service availability
The Drugdiag® 11 urine drug test, developed by the Toda Pharma laboratory (the leading rapid diagnostic test provider), allows simultaneous detection of 11 drug families, covering about 300 psychoactive substances. This multi-drug test is especially suited for companies, occupational physicians, addiction treatment centers, and law enforcement who need to secure high-responsibility environments.
The Drugdiag® 11 is presented as an easy-to-use urine test with visual reading of result strips. It is recommended for supervised screening campaigns, therapeutic monitoring, and targeted checks after incidents or accidents. Available individually or in boxes, it is distributed exclusively through AMA Prévention, the official distributor Toda Pharma based in Strasbourg.
Main uses of the Drugdiag® 11 urine drug test
High-responsibility positions and high-risk sectors
The Drugdiag® 11 urine test is particularly suitable for security and safety posts: road transport and logistics, construction, heavy industry, maintenance of sensitive installations, petrochemical platforms, energy, operation of classified sites. Complementing regulatory saliva tests, it enables a wider screening of recent or repeated consumptions, especially for substances not systematically searched for on the road (benzodiazepines, barbiturates, TCA, methadone, buprenorphine).
Therapeutic monitoring, addiction treatment, and medical care
Thanks to the detection of methadone (MTD), buprenorphine (BUP), and tricyclic antidepressants (TCA), the Drugdiag® 11 is a valuable tool for CSAPA, general practitioners, psychiatrists, clinics, and detox centers. It allows verification of adherence to substitution treatment, identification of associated consumptions (cocaine, amphetamines, opiates, benzodiazepines), and documentation of medical records in a clear and traceable framework.
Used with a supportive and non-blaming approach, this test contributes to structured follow-up, complementing clinical interviews and health authority recommendations.
Sensitive environments, internal investigations, and risk prevention
In companies, in accordance with article L.4121-1 of the Labor Code, the employer must take necessary measures to ensure the safety and protect the health of workers. When a workplace regulation provides for it, the Drugdiag® 11 urine test can be used within internal screening procedures: following an accident, dangerous behavior, or for targeted checks on particularly exposed positions.
AMA Prevention supports companies in implementing supportive screening campaigns, integrated into a comprehensive prevention policy (information, training, support).
Responsible self-monitoring and administrative procedures
The Drugdiag® 11 can also be used by individuals for self-monitoring (for example before a medical appointment, an occupational health interview, or an administrative procedure). It should be noted that only the result of a toxicological analysis in a laboratory is valid in the context of official judicial or administrative procedures.
Advantages of the Drugdiag® 11 drug urine test
- 11 drug families detected: broad coverage of about 300 psychoactive substances.
- Versatile tool: companies, occupational health, addiction treatment, medico-social structures, law enforcement.
- Quick reading: result in minutes after immersing the strip in urine.
- French design: designed and controlled by the Toda Pharma laboratory, the leader in rapid diagnostic testing.
- Medical quality: CE marking and ISO 13485 certification, full batch traceability.
- Practical format: packaging adapted for screening campaigns (single units or boxes).
- Clear visual interpretation: presence/absence of a colored band on each parameter.
- Integrable into a prevention policy: compatible with the requirements of the Joana Plan for transport and security stakeholders.
Detected substances and detection thresholds
The Drugdiag® 11 urine test allows detection of the following substances in urine, at thresholds adapted to professional and medical screening practices:
| Parameter | Main substance detected | Detection threshold |
|---|---|---|
| THC-COOH | Cannabis (main metabolite of THC) | 50 ng/mL |
| AMP | Amphetamines | 300 ng/mL |
| BAR | Barbiturates | 300 ng/mL |
| BZO | Benzodiazepines | 300 ng/mL |
| BUP | Buprenorphine | 10 ng/mL |
| COC | Cocaine and metabolites | 300 ng/mL |
| MDMA | Ecstasy (MDMA) | 500 ng/mL |
| MET | Methamphetamines | 300 ng/mL |
| MOP | Morphine / Opiates | 300 ng/mL |
| MTD | Methadone | 300 ng/mL |
| TCA | Tricyclic antidepressants | 1000 ng/mL |
The above values correspond to the usual cutoff thresholds for rapid urine screening tests. In case of a positive result, a confirmatory laboratory analysis may be performed according to current protocols.
Detection time of substances in urine
The detection time of drugs in urine depends on many factors: frequency of use, quantity, metabolism, health status, kidney function, hydration, etc. The durations below are given as an indication for a healthy adult.
| Substance | Approximate detection time |
|---|---|
| THC | 1 to 30 days depending on the frequency and intensity of consumption |
| AMP | 1 to 4 days after the last intake |
| BAR | 1 to 5 days after the last intake |
| BZO | 1 to 7 days (longer in case of prolonged treatments) |
| BUP | 1 to 7 days depending on the dose and duration of treatment |
| COC | 1 to 4 days after the last intake |
| MDMA | 1 to 3 days after the last intake |
| MET | 1 to 4 days after the last intake |
| MOP | 1 to 4 days after the last intake |
| MTD | 1 to 7 days depending on the therapeutic regimen |
| TCA | 1 to 7 days depending on the molecule and dosage |
These durations are indicative and can never constitute absolute proof of consumption or abstinence. They must always be interpreted in connection with the clinical context, the person's statements, and, if applicable, additional examinations.
Regulated use and compliance in the company
In the workplace, the use of screening tests must be provided for in the internal regulations, justified by the nature of the tasks (security or safety positions), and implemented in compliance with the Labor Code and employee rights. The occupational physician and staff representatives must be involved in the process.
The Drugdiag® 11 urine test is part of a comprehensive prevention policy, complementing actions of information, training, and support, and never replaces clinical evaluation or confirmatory laboratory analyses when these are required.
Clinical Expertise & Specificity
Advanced Colloidal Gold Technology
Our devices use competitive immunochromatography with colloidal gold-labeled antibodies, ensuring a clear, ultra-sensitive marking and medical-grade reliability.
Laboratory Certified Reliability (GC/MS)
The accuracy of this professional urinary screening device has been rigorously validated by comparative clinical studies. The results demonstrate an accuracy correlation greater than 99% compared to the global laboratory reference method (Gas Chromatography coupled with Mass Spectrometry - GC/MS).
Institutional Quality Labels
Designed and manufactured in France by the Toda Pharma Laboratory, this in vitro diagnostic medical device is certified ISO 13485 and bears the CE mark. Its high level of requirement has earned it certification by the UAF Label (Used by the French Armed Forces) and the Alsace Heart Label.
No cross-reactions (False Positives)
The high analytical specificity of the Toda Drugdiag® range guarantees the total absence of interference (tested up to a concentration of 100 μg/ml) with common consumer products. The urinary result will not be distorted by the presence of:
- Common medications: Aspirin (Acetylsalicylic acid), Ibuprofen, Paracetamol (Acetaminophen), Amoxicillin, Penicillin, cough syrups (Dextromethorphan).
- Physiological and dietary substances: Caffeine, Cholesterol, Hemoglobin, Creatinine, Vitamin C (Ascorbic acid), Uric acid.
Une solution de dépistage adaptée à chaque usage
Une solution fiable, rapide et simple à intégrer dans une démarche de prévention, adaptée aux conducteurs, entreprises, forces de l’ordre, professionnels de santé et particuliers.
Entreprises
Renforcez la sécurité des équipes avec des outils adaptés aux postes à risques et aux procédures internes.
Forces de l’ordre
Utilisez un matériel professionnel éprouvé pour les missions de contrôle, de prévention et d’intervention terrain.
Particuliers
Levez le doute simplement, favorisez le dialogue et adoptez une démarche responsable d’auto-contrôle.
Expertise médicale & conformité
Développé par un laboratoire français, ce dispositif s’inscrit dans une démarche de prévention documentée, avec des exigences de qualité, de traçabilité et de fiabilité adaptées aux usages professionnels.
Laboratoire français
CE / ISO 13485
Arrêté 13 décembre 2016
Utilisé par les Armées Françaises
French manufacturing and medical quality
Toda Pharma, a French manufacturer of drug screening tests, was one of the first European laboratories to develop a rapid serological test for coronavirus detection as early as February 2020 and was validated by the National Reference Center (CNR), the Pasteur Institute, and the French Ministry of Solidarity and Health.
A study was conducted in 3 hospitals by different operators on 3 separate batches of each drug at concentrations of 0ng/ml, +/- 25%, and +/- 50% of the detection threshold for the drug in question. All results met expectations. The detailed tables of all results are available to users upon request.
UAF Label – Reliability Recognized by Experts
Used by the French army for its screening tests, ensuring maximum accuracy and reliability.
The UAF label certifies that this test meets the highest standards, validated by the French armed forces. It offers a guarantee of quality and performance, providing screening as reliable as the tests used in military institutions.
The CE Standard
The CE certification guarantees that our products meet the essential safety, health, and environmental protection requirements set by the European Union. It certifies that our breathalyzers and drug screening tests comply with European standards, ensuring safe and reliable use. By choosing a CE certified product, you can be confident that it has been rigorously tested and meets the quality and safety standards in force on the European market.
The ISO 13485 Standard
The ISO 13485 standard is an international benchmark that certifies the quality of medical devices. This certification confirms that our manufacturing processes comply with the highest standards of quality and risk management. Our screening tests are designed and produced under strict conditions to ensure their reliability, safety, and effectiveness. By choosing our ISO 13485 certified products, you can be confident that you are using equipment that meets the medical sector’s requirements, delivering accurate and consistent results.
Bearer of the Cœur Alsace label
Toda Pharma is honored to receive the "Cœur Alsace" label, a symbol of excellence and commitment to our region. This prestigious label recognizes our dedication to high-quality, innovative local production that respects the strictest standards. Based in Strasbourg, Toda Pharma embodies Alsatian expertise in the service of health and public safety.